Clinical Trial Update: Adaptive Individualized High-Dose Radiotherapy Analysis-REctum-1 (AIDA-RE-1) [NA]

View source ↗

Summary

Clinical trial update on the AIDA-RE-1 study testing adaptive higher-dose radiotherapy for rectal cancer. The sponsor is IRCCS Azienda Ospedaliero-Universitaria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Rectal Cancer, Radiotherapy | NA | Status: UNKNOWN